udp-identifier-type-vs
type: ValueSet
node role: treeRoot
id:
  v: udp-identifier-type-vs
language:
  v: en
text:
  status:
    v: extensions
  div:
    v: Generated Narrative: ValueSet udp-identifier-type-vs Include these codes as defined in http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl version ?1.0.0-ballot2 Code Display Definition C132351 Sponsor Protocol Identifier A unique code, which is assigned by the sponsor, that identifies a specific protocol. C218672 Original Protocol Indicator An indication as to whether the protocol document reflects the original version of the protocol. C218477 Amendment Identifier A sequence of characters used to uniquely identify a protocol amendment. C218684 EU Clinical Trial Register Number A sequence of characters used to identify a clinical trial, as assigned by the Clinical Trials Information System (CTIS) of the European Medicines Agency. C218685 US FDA Investigational New Drug Application Number A sequence of characters used to identify a clinical trial under an Investigational New Drug (IND) application, as assigned by the US Food and Drug Administration. C218686 US FDA Investigational Device Exemption Application Number A sequence of characters used to identify a clinical trial under an Investigational Device Exemption (IDE) application, as assigned by the US Food and Drug Administration. C218687 Japan Registry for Clinical Trials Number A sequence of characters used to identify a clinical trial, as assigned by the Japan Registry for Clinical Trials (JRCT) of the Ministry of Health, Labour and Welfare (MHLW) in Japan. C172240 Clinicaltrials.gov Identifier The unique alphanumeric identifier for a trial as assigned by the Clinicaltrials.gov Protocol Registration and Results System (PRS). C218688 NMPA IND Number A sequence of characters used to identify a clinical trial under an Investigational New Drug (IND) application, as assigned by the Chinese National Medicinal Products Administration (NMPA). C218689 WHO/UTN Number A sequence of characters used to identify a clinical trial, as assigned by the World Health organization's International Clinical Trial's Registry Platform …
extension:
  url:
    v: http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm
    l: structuredefinition-fmm
  value: Integer
    v: 1
extension:
  url:
    v: http://hl7.org/fhir/StructureDefinition/structuredefinition-wg
    l: structuredefinition-wg
  value: Code
    v: brr
extension:
  url:
    v: http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status
    l: structuredefinition-standards-status
  value: Code
    v: trial-use
    extension:
      url:
        v: http://hl7.org/fhir/StructureDefinition/structuredefinition-conformance-derivedFrom
        l: structuredefinition-conformance-derivedFrom
      value: Canonical
        v: http://hl7.org/fhir/uv/clinical-study-protocol/ImplementationGuide/hl7.fhir.uv.clinical-study-protocol
        l: hl7.fhir.uv.clinical-study-protocol
url:
  v: http://hl7.org/fhir/uv/clinical-study-protocol/ValueSet/udp-identifier-type-vs
  l: udp-identifier-type-vs
version:
  v: 1.0.0-ballot2
name:
  v: UDPIdentifierType_VS
title:
  v: UDP Identifier Type Value Set
status:
  v: active
experimental:
  v: false
date:
  v: 2026-04-09T17:15:23+10:00
publisher:
  v: HL7 International / Biomedical Research and Regulation
contact:
  name:
    v: HL7 International / Biomedical Research and Regulation
  telecom:
    system:
      v: url
    value:
      v: http://www.hl7.org/Special/committees/rcrim
  telecom:
    system:
      v: email
description:
  v: These codes represent the types of identifier used ina study. This is a UDP specific value set. These are codes used in M11 but in the M11 Specification each code is associated with a distinct M11 attribute rather than being a classifier for a more general attribute. FHIR structures are designed to work with a repeating identifier attribute classified by an approriate terminology. This value set enables that by using NCIT codes to create a FHIR value set.
jurisdiction:
  coding:
    system:
      v: http://unstats.un.org/unsd/methods/m49/m49.htm
      l: m49.htm
    code:
      v: 001
    display:
      v: World
copyright:
  v: Portions of this material derives from the ICH M11 Harmonised Guideline CeSHarP. The ICH M11 Harmonised Guideline CeSHarP is copyright ©2025+ International Committee on Harmonisation and is made available under license. CDISC publishes semantics for the ICH M11 protocol data elements and valid value sets. This terminology set is published and stored in the NCI Thesaurus Subset C217023 - ICH M11 Terminology (https://evsexplore.semantics.cancer.gov/evsexplore/subset/ncit/C217023) The NCI Thesaurus is released under the CC BY 4.0 license For more licensing information and links see: [licenses.html](licenses.html)
compose:
  include:
    system:
      v: http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl
      l: Thesaurus.owl
    concept:
      code:
        v: C132351
      display:
        v: Sponsor Protocol Identifier
    concept:
      code:
        v: C218672
      display:
        v: Original Protocol Indicator
    concept:
      code:
        v: C218477
      display:
        v: Amendment Identifier
    concept:
      code:
        v: C218684
      display:
        v: EU Clinical Trial Register Number
    concept:
      code:
        v: C218685
      display:
        v: US FDA Investigational New Drug Application Number
    concept:
      code:
        v: C218686
      display:
        v: US FDA Investigational Device Exemption Application Number
    concept:
      code:
        v: C218687
      display:
        v: Japan Registry for Clinical Trials Number
    concept:
      code:
        v: C172240
      display:
        v: Clinicaltrials.gov Identifier
    concept:
      code:
        v: C218688
      display:
        v: NMPA IND Number
    concept:
      code:
        v: C218689
      display:
        v: WHO/UTN Number
    concept:
      code:
        v: C218690
      display:
        v: Other Regulatory or Clinical Trial Identifier